Daehwa Pharm. to patent an anti-cancer therapy.

Daehwa pharmaceutical company announced on Dec. 22 that the company developed an application method of Paclitaxel, an anti-cancer drug, to the chemical blocking therapy, a sort of liver cancer therapy, which was registered to the Patent Office.

The chemical blocking therapy is a kind of targeted solid tumor therapy like liver cancer without affecting other normal cells, by blockading an art...